cbdMD, Inc. (YCBD-PA) stock surged +18.51%, trading at $1.35 on AMEX, up from the previous close of $1.14. The stock opened at $1.14, fluctuating between $1.14 and $1.40 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 03, 2025 | 1.21 | 1.38 | 1.21 | 1.32 | 501.27K |
| Oct 02, 2025 | 1.14 | 1.44 | 1.14 | 1.19 | 5.39M |
| Oct 01, 2025 | 1.20 | 1.40 | 1.10 | 1.14 | 4.42M |
| Sep 30, 2025 | 1.25 | 1.25 | 1.05 | 1.21 | 6.56M |
| Sep 29, 2025 | 0.64 | 1.70 | 0.63 | 1.21 | 198.65M |
| Sep 26, 2025 | 0.55 | 0.57 | 0.53 | 0.55 | 94.81K |
| Sep 25, 2025 | 0.64 | 0.66 | 0.58 | 0.58 | 92.34K |
| Sep 24, 2025 | 0.60 | 0.63 | 0.60 | 0.60 | 56.78K |
| Sep 23, 2025 | 4.06 | 4.15 | 4.06 | 4.12 | 2.06M |
| Sep 22, 2025 | 0.63 | 0.68 | 0.63 | 0.66 | 71.21K |
| Sep 19, 2025 | 0.67 | 0.69 | 0.65 | 0.65 | 36.35K |
| Sep 18, 2025 | 0.70 | 0.71 | 0.68 | 0.71 | 1.13M |
| Sep 17, 2025 | 0.68 | 0.70 | 0.68 | 0.68 | 36.02K |
| Sep 16, 2025 | 0.65 | 0.73 | 0.65 | 0.70 | 110.76K |
| Sep 15, 2025 | 0.68 | 0.68 | 0.66 | 0.66 | 54.06K |
| Sep 12, 2025 | 0.68 | 0.70 | 0.67 | 0.67 | 60.47K |
| Sep 11, 2025 | 0.66 | 0.71 | 0.66 | 0.69 | 71.37K |
| Sep 10, 2025 | 0.66 | 0.69 | 0.66 | 0.67 | 44.01K |
| Sep 09, 2025 | 0.70 | 0.71 | 0.67 | 0.71 | 57.57K |
| Sep 08, 2025 | 0.72 | 0.72 | 0.67 | 0.67 | 75.22K |
cbdMD, Inc. specializes in the production and distribution of a wide variety of cannabidiol (CBD) products. The company manages a portfolio of its own hemp-derived CBD brands for consumers, including cbdMD, Paw CBD, and cbdMD Botanicals. Its primary brand, cbdMD, features an extensive selection of items such as CBD tinctures, edible gummies, topical creams, capsules, bath bombs, bath salts, and sleep aids. For animal companions, the Paw CBD brand provides veterinarian-formulated products, including tinctures, chews, and topical solutions. These goods are accessible to consumers throughout the United States via the company's dedicated e-commerce website, other online retail platforms, wholesale arrangements, and physical retail stores. Additionally, cbdMD, Inc. engages in a research partnership with the University of Mississippi to explore novel cannabinoids. The organization, which was initially known as Level Brands, Inc., rebranded as cbdMD, Inc. in May 2019. Established in 2015, its main offices are located in Charlotte, North Carolina.
| Employees | 42 |
| Beta | 2.77 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | September |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep